A lay prescription for tailor-made drugs--focus group reflections on pharmacogenomics
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
A lay prescription for tailor-made drugs--focus group reflections on pharmacogenomics. / Almarsdóttir, Anna Birna; Björnsdóttir, Ingunn; Traulsen, Janine Morgall.
In: Health Policy, Vol. 71, No. 2, 02.2005, p. 233-41.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - A lay prescription for tailor-made drugs--focus group reflections on pharmacogenomics
AU - Almarsdóttir, Anna Birna
AU - Björnsdóttir, Ingunn
AU - Traulsen, Janine Morgall
PY - 2005/2
Y1 - 2005/2
N2 - This study explores the lay view of pharmaceutical research and development--specifically pharmacogenomics. Forty-two persons participated in eight focus groups in Iceland. Participants were asked to comment on a future scenario consisting of predictions made by researchers concerning the consequences of the Human Genome Project over the next 40 years, and asked to give advice to politicians and the pharmaceutical industry. A dominating theme in the focus groups was the expectation that drugs developed based on pharmacogenomics will be more expensive than conventional mass produced drugs and concerns were voiced that this new technology would lead to inequalities locally and globally.
AB - This study explores the lay view of pharmaceutical research and development--specifically pharmacogenomics. Forty-two persons participated in eight focus groups in Iceland. Participants were asked to comment on a future scenario consisting of predictions made by researchers concerning the consequences of the Human Genome Project over the next 40 years, and asked to give advice to politicians and the pharmaceutical industry. A dominating theme in the focus groups was the expectation that drugs developed based on pharmacogenomics will be more expensive than conventional mass produced drugs and concerns were voiced that this new technology would lead to inequalities locally and globally.
KW - Adult
KW - Aged
KW - Drug Industry
KW - Female
KW - Focus Groups
KW - Humans
KW - Iceland
KW - Male
KW - Middle Aged
KW - Pharmacogenetics
KW - Journal Article
KW - Research Support, Non-U.S. Gov't
U2 - 10.1016/j.healthpol.2004.08.010
DO - 10.1016/j.healthpol.2004.08.010
M3 - Journal article
C2 - 15607385
VL - 71
SP - 233
EP - 241
JO - Health Policy
JF - Health Policy
SN - 0168-8510
IS - 2
ER -
ID: 170601680